Kay Tai Leung
Overview
Explore the profile of Kay Tai Leung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheung C, Lam M, Chow K, Lee W, Cheng Y, Yuen S, et al.
Ren Fail
. 2014 Mar;
36(6):865-9.
PMID: 24655030
Kidney transplant recipients have increased risk of cancers when compared with the general population. Hepatocellular carcinoma (HCC) is extremely important in Asia where hepatitis B virus (HBV) infection is endemic....
2.
Cheung C, Op den Buijsch R, Wong K, Chan H, Chau K, Li C, et al.
Pharmacogenomics
. 2006 Jun;
7(4):563-74.
PMID: 16753004
Tacrolimus has a narrow therapeutic window and a wide interindividual variation in its pharmacokinetics. The cytochrome P450 3A (CYP3A) and the ATP-binding cassette B1 (ABCB1) genes play an important role...
3.
Siu Y, Leung K, Tong M, Kwan T, Mok C
Nephrol Dial Transplant
. 2005 Oct;
20(12):2797-802.
PMID: 16204302
Objectives: The purpose of this study was to evaluate the outcome of systemic lupus erythematosus (SLE) patients on continuous ambulatory peritoneal dialysis (CAPD). Methods: Eighteen SLE patients who had been...
4.
Tong M, Leung K, Siu Y, Lee K, Lee H, Yung C, et al.
J Nephrol
. 2005 Jun;
18(2):204-8.
PMID: 15931649
Intraperitoneal (IP) urokinase is a fibrinolytic agent that has been used in the adjunctive treatment of continuous ambulatory peritoneal dialysis (CAPD) and resistant and relapsing peritonitis. However, its efficacy and...